APA (7th ed.) Citation

JW, C., J, B., S, S., JMS, B., T, P., MA, Q., . . . KJ, T. (2025). Adjunctive statistical standardization of quantitated adjuvant HER2 and ultra-low HER2 in Canadian Cancer Trials Group MA.27 trial of exemestane versus anastrozole. Breast cancer research and treatment, 213(1), 51. https://doi.org/10.1007/s10549-025-07749-9

Chicago Style (17th ed.) Citation

JW, Chapman, et al. "Adjunctive Statistical Standardization of Quantitated Adjuvant HER2 and Ultra-low HER2 in Canadian Cancer Trials Group MA.27 Trial of Exemestane Versus Anastrozole." Breast Cancer Research and Treatment 213, no. 1 (2025): 51. https://doi.org/10.1007/s10549-025-07749-9.

MLA (9th ed.) Citation

JW, Chapman, et al. "Adjunctive Statistical Standardization of Quantitated Adjuvant HER2 and Ultra-low HER2 in Canadian Cancer Trials Group MA.27 Trial of Exemestane Versus Anastrozole." Breast Cancer Research and Treatment, vol. 213, no. 1, 2025, p. 51, https://doi.org/10.1007/s10549-025-07749-9.